Jones Financial Companies
HUMA icon

Jones Financial Companies’s Humacyte HUMA Stock Holding History

Jones Financial Companies’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1K Buy
16,507
+3,755
+29% +$3.9K ﹤0.01% 3542
2025
Q4 		$12.2K Sell
12,752
-7,093
-36% -$10K ﹤0.01% 3132
2025
Q3 		$34.3K Buy
19,845
+700
+4% +$1.37K ﹤0.01% 2534
2025
Q2 		$40.6K Buy
19,145
+10,392
+119% +$20K ﹤0.01% 2308
2025
Q1 		$17.2K Buy
8,753
+6,953
+386% +$26.1K ﹤0.01% 2494
2024
Q4 		$9.09K Sell
1,800
-9,666
-84% -$47.8K ﹤0.01% 2563
2024
Q3 		$64K Buy
11,466
+300
+3% +$1.98K ﹤0.01% 1553
2024
Q2 		$53.6K Buy
+11,166
New +$58.1K ﹤0.01% 1232

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jones Financial Companies's HUMA Position: Q1 2026 in Review

Jones Financial Companies increased its Humacyte (HUMA) stake by 29% in Q1 2026, buying an estimated $3.9K and bringing the position to 16,507 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

Jones Financial Companies first reported a position in HUMA in Q2 2024 and has held it in 8 quarters since. The position peaked at $64K in Q3 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Jones Financial Companies held 16,507 shares of Humacyte worth $11.1K as of Q1 2026.
  • Jones Financial Companies bought 3,755 Humacyte shares in Q1 2026, an estimated $3.9K.
  • Humacyte made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3542 holding.
  • Jones Financial Companies first reported a position in Humacyte in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Humacyte position peaked at $64K in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.